80 related articles for article (PubMed ID: 27282150)
21. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
22. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.
Abdel Azim S; Duggan-Peer M; Sprung S; Reimer D; Fiegl H; Soleiman A; Marth C; Zeimet AG
Oncotarget; 2016 Jun; 7(24):37205-37214. PubMed ID: 27174921
[TBL] [Abstract][Full Text] [Related]
24. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
[TBL] [Abstract][Full Text] [Related]
25. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
26. Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients.
Sinha D; Chong L; George J; Schlüter H; Mönchgesang S; Mills S; Li J; Parish C; Bowtell D; Kaur P;
Clin Cancer Res; 2016 Apr; 22(7):1813-24. PubMed ID: 26589433
[TBL] [Abstract][Full Text] [Related]
27. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
Zhou X; Teng L; Wang M
Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
[TBL] [Abstract][Full Text] [Related]
28. Cautionary Note on Using Cross-Validation for Molecular Classification.
Qin LX; Huang HC; Begg CB
J Clin Oncol; 2016 Nov; 34(32):3931-3938. PubMed ID: 27601553
[TBL] [Abstract][Full Text] [Related]
29. Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.
Jakobsson ME; Moen A; Davidson B; Falnes PØ
PLoS One; 2015; 10(10):e0140168. PubMed ID: 26448330
[TBL] [Abstract][Full Text] [Related]
30. A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples.
Qin LX; Huang HC; Villafania L; Cavatore M; Olvera N; Levine DA
Sci Data; 2018 May; 5():180084. PubMed ID: 29762551
[TBL] [Abstract][Full Text] [Related]
31. Empirical evaluation of data normalization methods for molecular classification.
Huang HC; Qin LX
PeerJ; 2018; 6():e4584. PubMed ID: 29666754
[TBL] [Abstract][Full Text] [Related]
32. Blocking and randomization to improve molecular biomarker discovery.
Qin LX; Zhou Q; Bogomolniy F; Villafania L; Olvera N; Cavatore M; Satagopan JM; Begg CB; Levine DA
Clin Cancer Res; 2014 Jul; 20(13):3371-8. PubMed ID: 24788100
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA array normalization: an evaluation using a randomized dataset as the benchmark.
Qin LX; Zhou Q
PLoS One; 2014; 9(6):e98879. PubMed ID: 24905456
[TBL] [Abstract][Full Text] [Related]
34. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review.
Olsen M; Ghannad M; Lok C; Bossuyt PM
Clin Chem Lab Med; 2019 Dec; 58(1):3-10. PubMed ID: 30956227
[TBL] [Abstract][Full Text] [Related]
35. Statistical Assessment of Depth Normalization for Small RNA Sequencing.
Qin LX; Zou J; Shi J; Lee A; Mihailovic A; Farazi TA; Tuschl T; Singer S
JCO Clin Cancer Inform; 2020 Jun; 4():567-582. PubMed ID: 32598180
[TBL] [Abstract][Full Text] [Related]
36. An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study.
Qin LX; Tuschl T; Singer S
Cancer Inform; 2013; 12():83-101. PubMed ID: 23589668
[TBL] [Abstract][Full Text] [Related]
37. On data normalization and batch-effect correction for tumor subtyping with microRNA data.
Wu Y; Yuen BW; Wei Y; Qin LX
NAR Genom Bioinform; 2023 Mar; 5(1):lqac100. PubMed ID: 36632610
[TBL] [Abstract][Full Text] [Related]
38. Preprocessing Steps for Agilent MicroRNA Arrays: Does the Order Matter?
Qin LX; Huang HC; Zhou Q
Cancer Inform; 2014; 13(Suppl 4):105-9. PubMed ID: 26380547
[TBL] [Abstract][Full Text] [Related]
39. Study Design Considerations for Cancer Biomarker Discoveries.
Zheng Y
J Appl Lab Med; 2018 Sep; 3(2):282-289. PubMed ID: 30828695
[TBL] [Abstract][Full Text] [Related]
40. SUCCESSIVE NORMALIZATION OF RECTANGULAR ARRAYS.
Olshen RA; Rajaratnam B
Ann Stat; 2010 Jun; 38(3):1638-1664. PubMed ID: 20473354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
